文献速递腹部介入CTMR

腔壁贴合覆膜自膨胀金属支架治疗症状性胰周积液:CT与MRI对结局及并发症的评估

Lumen-apposing covered self-expanding metallic stent for symptomatic pancreatic fluid collections: assessment of outcomes and complications with CT and MRI.
PubMed 文献 · Abdom Radiol (NY) · 2020-07-17

回顾性纳入2015年3月至2018年6月接受腔壁贴合覆膜自膨胀金属支架(LAMS)置入的症状性胰周积液患者28例,技术成功27/28(96%),临床成功26/27(96%);随访影像显示积液体积由425 cm³降至0.6 cm³,降幅99.9%;并发症10/28(36%),再干预7/27(26%)。

要点

  • LAMS治疗症状性胰周积液的技术成功率和临床成功率均为96%。
  • 随访影像示积液体积由425 cm³降至0.6 cm³,降幅99.9%。
  • 常见并发症包括支架闭塞、支架移位、出血及假性动脉瘤形成。

关键影像表现/征象

  • 积液类型包括包裹性坏死21/28(75%)、假性囊肿5/28(18%)和急性坏死性积聚2/28(7%)。
  • 随访影像(至少1个月,n=24)显示积液体积由425 cm³(IQR 214-636)降至0.6 cm³(IQR 0-43.9),降幅99.9%。
  • 并发症10/28(36%)包括支架闭塞1例、支架移位3例、术中出血2例、术后出血2例及假性动脉瘤形成2例。

诊断标准与关键数值

  • 技术成功定义为成功置入支架并解决胰周积液,27/28(96%)达到。
  • 临床成功定义为支架取出后无积液复发,26/27(96%)达到。
  • 支架置入至取出的中位时间为42天(IQR 34-71)。
  • 再干预需求为7/27(26%)。

临床应用与阅片要点

  • 随访CT和MRI可用于评估LAMS置入后胰周积液体积变化及支架相关并发症。
  • 影像上需识别支架闭塞、支架移位、出血及假性动脉瘤形成等常见并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess technical and clinical outcomes following lumen-apposing covered self-expanding metallic stent (LAMS) placement for symptomatic pancreatic fluid collections (PFC) with CT and MRI.

METHODS: In this retrospective study, patients with PFC who underwent LAMS placement between March 2015 and June 2018 were included. Primary outcomes included technical success, defined as successful stent placement with resolution of PFC, and clinical success, defined as lack of fluid recurrence after stent removal. Secondary outcomes included time duration from stent placement to removal, complications, and re-intervention need.

RESULTS: 28 consecutive patients (20 men, mean age: 53 years ± 17; range 21-75) who underwent endoscopic drainage of symptomatic walled-off necrosis (WON, 21/28, 75%), pseudocyst (PC, 5/28, 18%) or acute necrotic collection (ANC, 2/28, 7%) were included. LAMS were placed successfully in 27/28 (96%) patients. On follow-up imaging after at least one month (n = 24), the volume of the PFC decreased by 99.9% from 425 cm3 [IQR 214 - 636] to 0.6 cm3 [IQR 0-43.9]. After stent removal, 26/27 (96%) patients remained collection free. The median time duration from stent placement to removal was 42 days [IQR 34-71]. Complications (10/28; 36%) included stent occlusion (n = 1), stent migration (n = 3), intraprocedural bleeding (n = 2), postprocedural bleeding (n = 2), and pseudoaneurysm formation (n = 2). Re-intervention was required in 7/27 (26%).

CONCLUSION: Following LAMS placement in patients with symptomatic PFC, high technical and clinical success rates of 96% and 96%, respectively, are achieved. Awareness of common complications seen on cross-sectional imaging might help radiologists and gastroenterologist in the patients' management.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Schawkat K, Luo M, Lee K, et al. Lumen-apposing covered self-expanding metallic stent for symptomatic pancreatic fluid collections: assessment of outcomes and complications with CT and MRI. Abdom Radiol (NY). 2020. PMID: 32681269. doi:10.1007/s00261-020-02638-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。